How Long Does the Lyme Vaccine Last in Dogs?

The Lyme vaccine for dogs provides protection for about 12 months, which is why veterinarians recommend annual boosters after the initial series. One newer vaccine product carries a 15-month duration label, the longest currently available, but the standard recommendation remains a booster every year. Antibody levels begin dropping well before that 12-month mark, so staying on schedule matters more with this vaccine than with many others.

Why Protection Fades Within a Year

The Lyme vaccine works by generating antibodies that target proteins on the surface of the bacteria that cause Lyme disease. These antibodies are ingested by the tick during feeding and actually kill the bacteria inside the tick’s gut before they can be transmitted to your dog. It’s an unusual mechanism: the vaccine fights the infection inside the tick, not inside your dog.

The problem is that these protective antibodies are relatively short-lived. A study published in Clinical and Vaccine Immunology found that while the vaccine provided a high level of protection for one year after immunization, certain key antibody levels had dropped to undetectable levels by day 394. Other important antibody types had also decreased significantly by that point. This is why an aggressive booster schedule is necessary. Unlike some vaccines that offer years of immunity, the Lyme vaccine requires consistent annual renewal to keep antibody levels high enough to neutralize bacteria during a tick bite.

The Vaccination Schedule

The American Animal Hospital Association (AAHA) guidelines lay out a straightforward schedule. Dogs receive two initial doses given 2 to 4 weeks apart, starting at 8 weeks of age or older. One year after completing that two-dose series, your dog gets a single booster. After that, it’s one booster annually for as long as the risk of tick exposure continues.

If you’re vaccinating because you’re traveling to a high-risk area, both initial doses should be completed at least 2 to 4 weeks before the trip. This gives your dog time to build adequate antibody levels before encountering infected ticks.

If you miss a booster and your dog is overdue, the AAHA guidelines don’t specify an exact cutoff for restarting the full two-dose series. They recommend checking with the vaccine manufacturer for specific instructions, but their general guidance is simple: when in doubt, vaccinate. Your vet can help determine whether your dog needs one booster or a fresh start with two doses.

How Effective Is the Vaccine?

The Lyme vaccine reduces infection risk meaningfully but doesn’t eliminate it entirely. A field study conducted in an endemic area of Connecticut found that 25% of vaccinated dogs became infected with the Lyme bacterium, compared to 63% of unvaccinated dogs. That translates to a preventive fraction of about 60%, and each vaccination dose decreased infection risk by 28%. These numbers reflect real-world conditions where dogs are naturally exposed to ticks, not a controlled laboratory setting.

This is why tick prevention products (topical treatments, collars, or oral medications) remain essential even for vaccinated dogs. The vaccine is a layer of protection, not a replacement for keeping ticks off your dog in the first place.

Types of Lyme Vaccines Available

Two main types of Lyme vaccines are used in dogs. Whole-cell bacterin vaccines contain killed bacteria and have been on the market the longest. These carry a USDA-approved 12-month duration of immunity, though some older bacterin products don’t have published duration data at all.

The newer option is a recombinant vaccine that targets two specific bacterial surface proteins rather than using whole killed bacteria. One recombinant product, VANGUARD crLyme, holds a 15-month duration of immunity label from the USDA, the longest of any Lyme vaccine currently available. A comprehensive field safety study of this vaccine found an excellent safety profile, with only minor reactions at low frequencies and no serious adverse events in healthy dogs 8 weeks or older.

Even with the 15-month product, most veterinarians still recommend annual boosters to keep things simple and ensure continuous protection, especially since tick season doesn’t wait for a convenient schedule.

Side Effects Are Uncommon

Among the bacterial-type vaccines commonly given to dogs (which include vaccines for kennel cough, Lyme, and leptospirosis), the Lyme vaccine falls in the middle for reported adverse events. It causes fewer reactions than the leptospirosis vaccine and slightly more than the kennel cough vaccine. The most common reactions are mild: temporary soreness at the injection site, slight lethargy, or a small amount of swelling. Serious reactions are rare.

Earlier formulations of bacterin-based Lyme vaccines did have higher reaction rates, but manufacturers have modified these products over the years specifically to reduce adverse events. The newer recombinant vaccines were designed in part to improve the safety profile further.

Is Your Dog a Good Candidate?

The Lyme vaccine is classified as a lifestyle vaccine, not a core vaccine. Whether your dog needs it depends primarily on geography and tick exposure. Lyme disease cases in the United States have expanded significantly since the mid-1990s, with the highest concentrations in the Northeast, upper Midwest, and mid-Atlantic states. If you live in or travel to these areas and your dog spends time outdoors in wooded or grassy environments, vaccination is worth considering.

For dogs in low-risk areas with minimal tick exposure, the vaccine may not be necessary. Your vet can help weigh the benefits against your dog’s specific lifestyle and location.

Checking Your Dog’s Protection Level

If you’re unsure whether your dog’s vaccine is still providing protection, a blood test called the Lyme Multiplex Assay can help. Developed at Cornell University, this test provides fully quantitative antibody measurements and can distinguish between antibodies produced by vaccination and those produced by natural infection. The test measures antibodies to the surface protein targeted by the vaccine as a direct marker of vaccination status. It’s useful for confirming that your dog responded to vaccination and for monitoring whether antibody levels remain adequate between boosters.